1. Home
  2. HG vs ARQT Comparison

HG vs ARQT Comparison

Compare HG & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HG
  • ARQT
  • Stock Information
  • Founded
  • HG 2013
  • ARQT 2016
  • Country
  • HG Bermuda
  • ARQT United States
  • Employees
  • HG N/A
  • ARQT N/A
  • Industry
  • HG
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HG
  • ARQT Health Care
  • Exchange
  • HG Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • HG 2.2B
  • ARQT 1.7B
  • IPO Year
  • HG 2023
  • ARQT 2020
  • Fundamental
  • Price
  • HG $21.13
  • ARQT $14.29
  • Analyst Decision
  • HG Buy
  • ARQT Strong Buy
  • Analyst Count
  • HG 6
  • ARQT 7
  • Target Price
  • HG $24.17
  • ARQT $18.67
  • AVG Volume (30 Days)
  • HG 422.6K
  • ARQT 1.5M
  • Earning Date
  • HG 08-06-2025
  • ARQT 08-06-2025
  • Dividend Yield
  • HG N/A
  • ARQT N/A
  • EPS Growth
  • HG N/A
  • ARQT N/A
  • EPS
  • HG 3.03
  • ARQT N/A
  • Revenue
  • HG $2,443,695,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • HG $14.65
  • ARQT $61.01
  • Revenue Next Year
  • HG $11.40
  • ARQT $37.95
  • P/E Ratio
  • HG $6.98
  • ARQT N/A
  • Revenue Growth
  • HG 27.70
  • ARQT 100.03
  • 52 Week Low
  • HG $15.31
  • ARQT $7.86
  • 52 Week High
  • HG $22.33
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • HG 48.42
  • ARQT 46.02
  • Support Level
  • HG $21.22
  • ARQT $14.44
  • Resistance Level
  • HG $21.71
  • ARQT $15.38
  • Average True Range (ATR)
  • HG 0.45
  • ARQT 0.66
  • MACD
  • HG -0.00
  • ARQT -0.09
  • Stochastic Oscillator
  • HG 40.62
  • ARQT 10.19

About HG Hamilton Insurance Group Ltd. Class B

Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: